The Effects of Tyrosol and Creatine on Endurance, Strength, and Fatigue Resistance in Healthy Adults
Launched by APPLIED SCIENCE & PERFORMANCE INSTITUTE · Mar 12, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two substances, tyrosol and creatine, on physical performance, including endurance (how long you can exercise), strength (how much weight you can lift), and resistance to fatigue (how long you can keep going without getting tired). Over four weeks, participants will take one of four options: tyrosol, a placebo (a substance with no active ingredient), creatine, or a combination of both tyrosol and creatine. Researchers will measure how these substances affect different physical abilities through various tests at the beginning and end of the study.
To participate, you should be a healthy adult aged 18 to 50 who exercises regularly (at least twice a week) and meets certain health criteria. You will need to agree not to take other supplements that could affect your muscle strength or endurance during the study. If you join, you can expect to have your body composition, strength, and endurance tested multiple times, along with completing questionnaires about how you feel. This trial is a great opportunity to help researchers learn more about how tyrosol and creatine may work together to improve athletic performance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy males or females aged 18-50
- • Currently active (engaged in moderate to vigorous activity at least 2-days per week as defined by the American College of Sports Medicine Guidelines)
- • Estimated VO2 max equal to or greater than the 50th percentile of the population norm for age (assessed via ACSM guidelines, 2014). The VO2 max estimation at screening will be obtained by following a non-exercise regression model validated and described by Bradshaw et al. (2005).
- • Able to read and write in English
- • During the study, agree not to take any other supplements that may increase muscle strength or endurance (e.g. protein formulas, creatine, amino acids, tyrosol or stimulants other than caffeine).
- • Females willing to share days menstrual cycle for testing purposes as shifts in hormone levels may, potentially, affect testing
- Exclusion Criteria:
- • Known diagnosis of any cardiovascular, metabolic, endocrine, or renal disease
- • Recent musculoskeletal injury (\<3-months)
- • Recent orthopaedic surgery (\<12-months)
- • History or current malignancy
- • Previous gastrointestinal surgery within the past 12 months
- • Regular smoker
- • Regular drinker (\>14 drinks per week)
- • Current use (within the past 4 weeks) of creatine supplements
- • Current use (within past 3 months) of Tyrosol supplementation
- • Current use of dietary supplements that may enhance mitochondrial function, muscle hypertrophy, or muscle strength (e.g. protein formulas, creatine, amino acids, tyrosol, etc.).
- • Current use of prescription medications that may influence adaptation to exercise (hormone therapies, peptides, etc.)
- • Female subjects who do not test negative on a urine pregnancy test or are lactating.
About Applied Science & Performance Institute
The Applied Science & Performance Institute (ASPI) is a leading clinical trial sponsor dedicated to advancing the fields of health, nutrition, and performance through rigorous scientific research. With a commitment to innovative methodologies and evidence-based practices, ASPI collaborates with a diverse network of researchers, healthcare professionals, and industry partners to conduct clinical trials that explore cutting-edge interventions and enhance human performance. By prioritizing ethical standards and regulatory compliance, ASPI aims to contribute valuable insights that inform clinical practices and promote optimal health outcomes across various populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
Patients applied
Trial Officials
Eric Sikorski, PhD
Principal Investigator
Applied Science and Performance Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported